Immediate Impact
63 standout
Citing Papers
Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
2024 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Works of Keisuke Mitsuoka being referenced
SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Keisuke Mitsuoka | 219 | 202 | 58 | 155 | 18 | 534 | |
| Richard E. Schell | 120 | 334 | 43 | 128 | 18 | 588 | |
| Gian Carlo Lunazzi | 241 | 206 | 21 | 113 | 23 | 563 | |
| M. Perenna Rogers | 150 | 310 | 61 | 122 | 29 | 602 | |
| Chizuru Watanabe | 125 | 196 | 72 | 228 | 19 | 577 | |
| Eugene C. Chen | 273 | 218 | 90 | 91 | 13 | 592 | |
| Mayumi Mukai | 308 | 177 | 85 | 142 | 19 | 569 | |
| Bengt Frode Kase | 125 | 276 | 59 | 81 | 19 | 558 | |
| Su Sien Ong | 196 | 185 | 29 | 102 | 15 | 548 | |
| J Fauvel | 77 | 317 | 22 | 154 | 25 | 631 | |
| Tomoaki Inoue | 64 | 259 | 25 | 153 | 20 | 621 |
All Works
Loading papers...